302 related articles for article (PubMed ID: 27261608)
1. Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.
Asghari F; Haghnavaz N; Baradaran B; Hemmatzadeh M; Kazemi T
Biomed Pharmacother; 2016 Jul; 81():305-317. PubMed ID: 27261608
[TBL] [Abstract][Full Text] [Related]
2. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
Kaboli PJ; Rahmat A; Ismail P; Ling KH
Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and microRNAs: therapeutic impact.
Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
[TBL] [Abstract][Full Text] [Related]
6. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
[TBL] [Abstract][Full Text] [Related]
7. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention.
Sengupta D; Deb M; Kar S; Pradhan N; Parbin S; Kirtana R; Singh SP; Suma SG; Niharika ; Roy A; Manna S; Saha P; Chakraborty P; Dash S; Kausar C; Patra SK
Semin Cancer Biol; 2021 Jul; 72():46-64. PubMed ID: 32497683
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeutics.
Hussen BM; Salihi A; Abdullah ST; Rasul MF; Hidayat HJ; Hajiesmaeili M; Ghafouri-Fard S
Pathol Res Pract; 2022 Feb; 230():153764. PubMed ID: 35032831
[TBL] [Abstract][Full Text] [Related]
9. The role of oncomirs in the pathogenesis and treatment of breast cancer.
Hemmatzadeh M; Mohammadi H; Jadidi-Niaragh F; Asghari F; Yousefi M
Biomed Pharmacother; 2016 Mar; 78():129-139. PubMed ID: 26898434
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
[TBL] [Abstract][Full Text] [Related]
13. Regulation of breast cancer metastasis signaling by miRNAs.
Petri BJ; Klinge CM
Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859
[TBL] [Abstract][Full Text] [Related]
14. Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer.
Samantarrai D; Dash S; Chhetri B; Mallick B
Mol Cancer Res; 2013 Apr; 11(4):315-28. PubMed ID: 23360796
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as Biomarker for Breast Cancer.
Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
[TBL] [Abstract][Full Text] [Related]
16. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
Otmani K; Rouas R; Lewalle P
Front Immunol; 2022; 13():913951. PubMed ID: 36189271
[TBL] [Abstract][Full Text] [Related]
17. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.
Lutful Kabir FM; DeInnocentes P; Bird RC
J Cell Biochem; 2015 Dec; 116(12):2956-69. PubMed ID: 26095675
[TBL] [Abstract][Full Text] [Related]
18. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
Yamamoto H; Mori M
Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.
Wang W; Luo YP
J Zhejiang Univ Sci B; 2015 Jan; 16(1):18-31. PubMed ID: 25559952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
